Determining the appropriate retatrutide amount is vitally essential for obtaining desired benefits. Initially, patients typically begin with a introductory dose of approximately 2.4 mg, provided each week via injection. This preliminary dose is then incrementally raised every four periods, until a peak dose of 10.8 mg, based on person reaction and